echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The Center for Drug Evaluation of the State Food and Drug Administration released the "Annual Report on the Progress of New Drug Registration Clinical Trials in China (2021)"

    The Center for Drug Evaluation of the State Food and Drug Administration released the "Annual Report on the Progress of New Drug Registration Clinical Trials in China (2021)"

    • Last Update: 2022-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In order to fully grasp the progress of clinical trials for new drug registration in China, use information technology to improve drug supervision capabilities, disclose clinical trial progress information in a timely manner, and provide reference for new drug research and development, resource allocation, and drug review and approval, the Center for Drug Evaluation is based on the registration and approval of drug clinical tria.


    This annual report is mainly based on the information of drug clinical trials registered in 2021, including drug types, varieties and target characteristics, indications, sponsor types, registration classification, trial classification, trial staging, special population trials, and clinical trial team leader uni.


    Attachment: Annual Report on Progress of Clinical Trials for New Drug Registration in China (2021)

    Drug Evaluation Center of the State Food and Drug Administration

    June 7, 2022

    Relevant attachments

    serial number accessory name
    1 "Annual Report on Progress of Clinical Trials for New Drug Registration in China (2021.
    pdf
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.